- about us
- medical affairs
- investors & media
- Email Alerts
- Contact Us
Dr. Sebastian Mirkin is Chief Medical Officer at TherapeuticsMD. Dr. Mirkin has more than 15 years of clinical development and medical affairs experience in women’s health. His experience includes Global Lead of Women’s Health Clinical Research at Pfizer; Senior Director Clinical Research, Women’s Health at Wyeth; and Global Lead Medical Services at Organon. Dr. Mirkin oversaw the development and successful marketing authorization of several novel medicines including Duavee®, Conbriza®, Lybrel® and Premarin® Vaginal Cream in the United States, Europe, and Japan. Dr. Mirkin holds a Doctor of Medicine degree from National University, Argentina.
Trained in obstetrics/gynecology, Dr. Mirkin completed his fellowship in Reproductive Medicine at the Jones Institute of Reproductive Medicine in Norfolk, Virginia, and was involved in several NIH and pharmaceutical-sponsored clinical trials in reproduction, contraception, and menopausal health.
Dr. Mirkin’s awards include the New Young Investigator Award from the North American Menopause Society and the Burroughs Fellowship Award from the Society for Gynecological Investigation. Published extensively in the fields of menopause, contraception, and reproductive endocrinology, Dr. Mirkin is an ad hoc reviewer for multiple women’s health-related journals.